Health Canada aprueba vacunas de Moderna contra gripe y gripe-COVID para mayores

Health Canada aprueba vacunas de Moderna contra gripe y gripe-COVID para mayores

Health Canada aprobó la vacuna contra la gripe mFLUSIVA de Moderna y la vacuna combinada mCOFLU contra gripe y COVID-19 para adultos de 50 años o más el 5 de noviembre, convirtiéndose en el primer país en autorizar ambos productos. Según CBC, la autorización sitúa a Canadá como pionero en otorgar la autorización regulatoria a las dos vacunas, y la noticia se informó el 6 de noviembre. La aprobación se produjo tras la presentación por parte de Moderna de datos sobre la seguridad y eficacia de la vacuna de ARNm contra la gripe y la combinación gripe-COVID, que fueron evaluados por los reguladores antes de conceder el visto bueno.

Actores

Health Canada Moderna The Canadian Press National Advisory Committee on Immunization Pfizer

Ubicaciones

Canada United States Europe

Verificación de hechos

Cómo funcionan estas métricas
Veredicto general: Parcial Confianza: 50% Afirmaciones: 2
Resumen

There is not enough evidence to confirm that Health Canada authorized Moderna's combined flu-COVID-19 shot for adults aged 50 and older on November 6, 2026. There is also insufficient evidence to verify that Health Canada authorized Moderna's mRNA influenza vaccine for adults aged 50 and older on the same date. It is partially confirmed that Canada is the first country to approve both Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot for adults 50 and older. The claim that Moderna stated their authorized vaccines will not be available in pharmacies before the upcoming respiratory virus season is refuted.

Inicia sesión o suscríbete para ver el análisis completo con afirmaciones, fuentes y validación cronológica.

Esta sección contiene una verificación automatizada de afirmaciones con fuentes externas y puede incluir imprecisiones.

Artículos

6 de noviembre de 2026
6 en total
Health Canada approves Moderna’s combined COVID, flu shot for some
Health Canada approves Moderna’s combined COVID, flu shot for some

Global News • 6 de nov 18:55

Health Canada approved Moderna's mFLUSIVA flu vaccine and mCOFLU combined flu-COVID shot for adults aged 50 and older, marking the first country to authorize both products.

Credibilidad 88% Manip. 8% Centro
Moderna's mRNA flu and flu-COVID combo vaccines have been approved by Health Canada
Moderna's mRNA flu and flu-COVID combo vaccines have been approved by Health Canada

CBC • 6 de nov 16:39

Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot have been authorized for adults 50 and older, making Canada the first country to approve both products.

Credibilidad 92% Manip. 8% Centro
New mRNA vaccines approved by Health Canada
New mRNA vaccines approved by Health Canada

CHCH • 6 de nov 12:42

Health Canada has authorized a combined mRNA COVID-19 and influenza vaccine from Moderna for use in Canada.

Credibilidad 32% Manip. 8% Centro
Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines
Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines

CityNews Vancouver • 6 de nov 00:36

Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot have received approval for adults 50 and older, though the company says distribution will miss the upcoming respiratory season.

Credibilidad 88% Manip. 5% Centro
Health Canada approves Moderna’s mRNA flu and flu-COVID combo vaccines
Health Canada approves Moderna’s mRNA flu and flu-COVID combo vaccines

CKPG Today • 6 de nov 00:23

Health Canada has approved Moderna's standalone influenza vaccine, mFLUSIVA, and its combined flu-COVID-19 vaccine, mCOFLU, for adults aged 50 and older, making Canada the first country to authorize both products.

Credibilidad 88% Manip. 8% Centro
Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines
Health Canada approves Moderna's mRNA flu and flu-COVID combo vaccines

CityNews Toronto • 6 de nov 00:19

Moderna's mRNA influenza vaccine and its combined flu-COVID-19 shot have been approved by Health Canada for adults aged 50 and older, though the company says they will not reach pharmacies before the upcoming respiratory virus season.

Credibilidad 88% Manip. 5% Centro